![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: FBP1 |
Gene summary for FBP1 |
![]() |
Gene information | Species | Human | Gene symbol | FBP1 | Gene ID | 2203 |
Gene name | fructose-bisphosphatase 1 | |
Gene Alias | FBP | |
Cytomap | 9q22.32 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | P09467 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
2203 | FBP1 | HTA11_1938_2000001011 | Human | Colorectum | AD | 3.61e-02 | 3.22e-01 | -0.0811 |
2203 | FBP1 | HTA11_1391_2000001011 | Human | Colorectum | AD | 3.96e-09 | 6.07e-01 | -0.059 |
2203 | FBP1 | HTA11_866_3004761011 | Human | Colorectum | AD | 2.99e-02 | 2.81e-01 | 0.096 |
2203 | FBP1 | HTA11_7696_3000711011 | Human | Colorectum | AD | 3.50e-02 | 2.47e-01 | 0.0674 |
2203 | FBP1 | HTA11_6818_2000001021 | Human | Colorectum | AD | 1.05e-02 | 2.69e-01 | 0.0588 |
2203 | FBP1 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 6.08e-09 | 4.21e-01 | 0.3859 |
2203 | FBP1 | LZE24T | Human | Esophagus | ESCC | 9.58e-06 | 2.63e-01 | 0.0596 |
2203 | FBP1 | P8T-E | Human | Esophagus | ESCC | 9.53e-09 | 1.91e-01 | 0.0889 |
2203 | FBP1 | P28T-E | Human | Esophagus | ESCC | 5.15e-11 | 3.01e-01 | 0.1149 |
2203 | FBP1 | P57T-E | Human | Esophagus | ESCC | 1.78e-03 | 1.06e-01 | 0.0926 |
2203 | FBP1 | P74T-E | Human | Esophagus | ESCC | 3.83e-04 | 2.67e-01 | 0.1479 |
2203 | FBP1 | P75T-E | Human | Esophagus | ESCC | 2.70e-39 | 1.11e+00 | 0.1125 |
2203 | FBP1 | P76T-E | Human | Esophagus | ESCC | 1.96e-05 | 1.24e-01 | 0.1207 |
2203 | FBP1 | P82T-E | Human | Esophagus | ESCC | 9.61e-07 | 5.53e-01 | 0.1072 |
2203 | FBP1 | P94T-E | Human | Esophagus | ESCC | 1.55e-13 | 1.76e+00 | 0.0879 |
2203 | FBP1 | P104T-E | Human | Esophagus | ESCC | 3.89e-05 | 4.92e-01 | 0.0931 |
2203 | FBP1 | P130T-E | Human | Esophagus | ESCC | 1.75e-25 | 5.56e-01 | 0.1676 |
2203 | FBP1 | NAFLD1 | Human | Liver | NAFLD | 4.79e-07 | 5.92e-01 | -0.04 |
2203 | FBP1 | S43 | Human | Liver | Cirrhotic | 1.95e-17 | -2.48e-01 | -0.0187 |
2203 | FBP1 | HCC1_Meng | Human | Liver | HCC | 5.66e-30 | -4.31e-01 | 0.0246 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00460347 | Liver | NAFLD | ATP metabolic process | 46/1882 | 277/18723 | 4.55e-04 | 6.69e-03 | 46 |
GO:00434676 | Liver | NAFLD | regulation of generation of precursor metabolites and energy | 26/1882 | 130/18723 | 4.78e-04 | 6.78e-03 | 26 |
GO:00015585 | Liver | NAFLD | regulation of cell growth | 63/1882 | 414/18723 | 5.50e-04 | 7.46e-03 | 63 |
GO:00310993 | Liver | NAFLD | regeneration | 35/1882 | 198/18723 | 6.67e-04 | 8.61e-03 | 35 |
GO:00075687 | Liver | NAFLD | aging | 53/1882 | 339/18723 | 7.78e-04 | 9.77e-03 | 53 |
GO:00465802 | Liver | NAFLD | negative regulation of Ras protein signal transduction | 13/1882 | 49/18723 | 8.43e-04 | 1.03e-02 | 13 |
GO:0062014 | Liver | NAFLD | negative regulation of small molecule metabolic process | 21/1882 | 102/18723 | 1.09e-03 | 1.27e-02 | 21 |
GO:0043255 | Liver | NAFLD | regulation of carbohydrate biosynthetic process | 20/1882 | 97/18723 | 1.39e-03 | 1.56e-02 | 20 |
GO:0045820 | Liver | NAFLD | negative regulation of glycolytic process | 6/1882 | 14/18723 | 1.51e-03 | 1.64e-02 | 6 |
GO:00061402 | Liver | NAFLD | regulation of nucleotide metabolic process | 18/1882 | 86/18723 | 1.98e-03 | 1.98e-02 | 18 |
GO:19035787 | Liver | NAFLD | regulation of ATP metabolic process | 18/1882 | 87/18723 | 2.26e-03 | 2.19e-02 | 18 |
GO:0045912 | Liver | NAFLD | negative regulation of carbohydrate metabolic process | 12/1882 | 48/18723 | 2.30e-03 | 2.19e-02 | 12 |
GO:0010677 | Liver | NAFLD | negative regulation of cellular carbohydrate metabolic process | 11/1882 | 42/18723 | 2.32e-03 | 2.19e-02 | 11 |
GO:00480091 | Liver | NAFLD | insulin-like growth factor receptor signaling pathway | 10/1882 | 37/18723 | 2.82e-03 | 2.56e-02 | 10 |
GO:00459275 | Liver | NAFLD | positive regulation of growth | 40/1882 | 259/18723 | 4.00e-03 | 3.35e-02 | 40 |
GO:00303075 | Liver | NAFLD | positive regulation of cell growth | 28/1882 | 166/18723 | 4.35e-03 | 3.57e-02 | 28 |
GO:0045980 | Liver | NAFLD | negative regulation of nucleotide metabolic process | 7/1882 | 23/18723 | 5.91e-03 | 4.47e-02 | 7 |
GO:00060002 | Liver | NAFLD | fructose metabolic process | 5/1882 | 13/18723 | 6.58e-03 | 4.69e-02 | 5 |
GO:0006111 | Liver | NAFLD | regulation of gluconeogenesis | 11/1882 | 48/18723 | 7.00e-03 | 4.90e-02 | 11 |
GO:002261312 | Liver | Cirrhotic | ribonucleoprotein complex biogenesis | 231/4634 | 463/18723 | 3.28e-32 | 6.86e-29 | 231 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa01200 | Colorectum | AD | Carbon metabolism | 55/2092 | 115/8465 | 5.53e-08 | 8.42e-07 | 5.37e-07 | 55 |
hsa00010 | Colorectum | AD | Glycolysis / Gluconeogenesis | 34/2092 | 67/8465 | 3.63e-06 | 4.34e-05 | 2.77e-05 | 34 |
hsa04152 | Colorectum | AD | AMPK signaling pathway | 47/2092 | 121/8465 | 3.74e-04 | 2.82e-03 | 1.80e-03 | 47 |
hsa04922 | Colorectum | AD | Glucagon signaling pathway | 41/2092 | 107/8465 | 1.18e-03 | 7.75e-03 | 4.94e-03 | 41 |
hsa00051 | Colorectum | AD | Fructose and mannose metabolism | 17/2092 | 34/8465 | 1.25e-03 | 8.02e-03 | 5.12e-03 | 17 |
hsa012001 | Colorectum | AD | Carbon metabolism | 55/2092 | 115/8465 | 5.53e-08 | 8.42e-07 | 5.37e-07 | 55 |
hsa000101 | Colorectum | AD | Glycolysis / Gluconeogenesis | 34/2092 | 67/8465 | 3.63e-06 | 4.34e-05 | 2.77e-05 | 34 |
hsa041521 | Colorectum | AD | AMPK signaling pathway | 47/2092 | 121/8465 | 3.74e-04 | 2.82e-03 | 1.80e-03 | 47 |
hsa049221 | Colorectum | AD | Glucagon signaling pathway | 41/2092 | 107/8465 | 1.18e-03 | 7.75e-03 | 4.94e-03 | 41 |
hsa000511 | Colorectum | AD | Fructose and mannose metabolism | 17/2092 | 34/8465 | 1.25e-03 | 8.02e-03 | 5.12e-03 | 17 |
hsa000104 | Colorectum | MSS | Glycolysis / Gluconeogenesis | 28/1875 | 67/8465 | 2.36e-04 | 1.81e-03 | 1.11e-03 | 28 |
hsa049224 | Colorectum | MSS | Glucagon signaling pathway | 39/1875 | 107/8465 | 5.00e-04 | 3.45e-03 | 2.11e-03 | 39 |
hsa041522 | Colorectum | MSS | AMPK signaling pathway | 41/1875 | 121/8465 | 1.91e-03 | 9.83e-03 | 6.03e-03 | 41 |
hsa04910 | Colorectum | MSS | Insulin signaling pathway | 43/1875 | 137/8465 | 7.37e-03 | 2.84e-02 | 1.74e-02 | 43 |
hsa000105 | Colorectum | MSS | Glycolysis / Gluconeogenesis | 28/1875 | 67/8465 | 2.36e-04 | 1.81e-03 | 1.11e-03 | 28 |
hsa049225 | Colorectum | MSS | Glucagon signaling pathway | 39/1875 | 107/8465 | 5.00e-04 | 3.45e-03 | 2.11e-03 | 39 |
hsa041523 | Colorectum | MSS | AMPK signaling pathway | 41/1875 | 121/8465 | 1.91e-03 | 9.83e-03 | 6.03e-03 | 41 |
hsa049101 | Colorectum | MSS | Insulin signaling pathway | 43/1875 | 137/8465 | 7.37e-03 | 2.84e-02 | 1.74e-02 | 43 |
hsa0120023 | Esophagus | ESCC | Carbon metabolism | 79/4205 | 115/8465 | 2.50e-05 | 1.21e-04 | 6.22e-05 | 79 |
hsa0415210 | Esophagus | ESCC | AMPK signaling pathway | 80/4205 | 121/8465 | 1.73e-04 | 6.67e-04 | 3.42e-04 | 80 |
Page: 1 2 3 4 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FBP1 | SNV | Missense_Mutation | novel | c.1007N>T | p.Ser336Phe | p.S336F | P09467 | protein_coding | deleterious(0.01) | benign(0.284) | TCGA-A8-A08L-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
FBP1 | SNV | Missense_Mutation | c.747N>A | p.Met249Ile | p.M249I | P09467 | protein_coding | deleterious(0) | possibly_damaging(0.476) | TCGA-A8-A09I-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | anastrozole | SD | |
FBP1 | SNV | Missense_Mutation | novel | c.145G>C | p.Val49Leu | p.V49L | P09467 | protein_coding | deleterious(0.02) | benign(0.366) | TCGA-AR-A2LE-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | PD |
FBP1 | SNV | Missense_Mutation | novel | c.923N>T | p.Pro308Leu | p.P308L | P09467 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-AR-A5QM-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | anastrozole | PD |
FBP1 | SNV | Missense_Mutation | novel | c.323N>A | p.Pro108Gln | p.P108Q | P09467 | protein_coding | tolerated(0.21) | benign(0.028) | TCGA-VS-A9UJ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD |
FBP1 | SNV | Missense_Mutation | novel | c.299N>C | p.Asp100Ala | p.D100A | P09467 | protein_coding | tolerated(0.05) | benign(0.069) | TCGA-AA-A02R-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
FBP1 | SNV | Missense_Mutation | c.88N>A | p.Glu30Lys | p.E30K | P09467 | protein_coding | deleterious(0) | benign(0.247) | TCGA-AZ-6599-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
FBP1 | SNV | Missense_Mutation | novel | c.931N>G | p.Ile311Val | p.I311V | P09467 | protein_coding | deleterious(0.02) | possibly_damaging(0.47) | TCGA-G4-6295-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FBP1 | deletion | Frame_Shift_Del | c.881delN | p.Gly294GlufsTer11 | p.G294Efs*11 | P09467 | protein_coding | TCGA-A6-5661-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
FBP1 | SNV | Missense_Mutation | novel | c.1010N>T | p.Ala337Val | p.A337V | P09467 | protein_coding | tolerated(0.08) | benign(0) | TCGA-A5-A0G1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
2203 | FBP1 | DRUGGABLE GENOME, ENZYME | MB07803 | MB-07803 | ||
2203 | FBP1 | DRUGGABLE GENOME, ENZYME | MB07803 | MB-07803 | ||
2203 | FBP1 | DRUGGABLE GENOME, ENZYME | Managlinat dialanetil |
Page: 1 |